BSE Code: | NSE Code: | ISIN: | Sector:
Research Report Detail
|Report Date||Call||Price@Call||Target Price
|Current Status||Time Horizon|
CLSA maintains buy on Sun Pharma
See a low probability of an import alert on Halol plant. Any weakness in stock is a buying opportunity. Halol plant is likely to recover in half of 2018. Expect earnings growth recovery from third quarter of 2016.